Cigarette smoke
3 papers5 findings
- 3 independent labs in 3 countries
- 1 trial
- Funders: Fondation du Souffle and 1 more
- Animals1
- Cells1
Outcomes
5MMP2 and MMP7 expression
upin human cells1
1 study
MMP2 and MMP7 expression
upin human cells1
Cigarette smoke increases MMP2 and MMP7 expression in human cells.
“MMP2 and MMP7 expression levels increased only by RC”
Cells1R6F reference cigarette smoke extractTIG-1 lung fibroblasts
Geriatrics & gerontology international1 Mar 2026
VEGFA
upin human cells1
1 study
VEGFA
upin human cells1
Cigarette smoke increases VEGFA in human cells.
“CCR6+ Th17 cells showed a higher sensitivity to CSE-induced senescence compared to controls, which is associated to oxidative stress and higher VEGFα secretion.”
Cellsin CCR6+ Th17 lymphocytescigarette smoke extract
Cigarette smoking induces human CCR6⁺Th17 lymphocytes senescence and VEGF-A secretion
Scientific reports16 Apr 2020
Cellular senescence
upin human cells1
1 study
Cellular senescence
upin human cells1
Cigarette smoke induces cellular senescence in human cells.
“CCR6+ Th17 cells showed a higher sensitivity to CSE-induced senescence compared to controls”
Cellsin cultured lymphocytescigarette smoke extract
Cigarette smoking induces human CCR6⁺Th17 lymphocytes senescence and VEGF-A secretion
Scientific reports16 Apr 2020
Emphysema
upin humans1
1 study
Emphysema
upin humans1
Cigarette smoke induces emphysema in humans.
“Emphysematous changes in the lung take years to develop after exposure to cigarette smoke”
Reviewchronic exposure
Chronic obstructive pulmonary disease and the hallmarks of aging
Lung India : official organ of Indian Chest Society1 Jan 2018
Inflammation
upin humans1
1 study
Inflammation
upin humans1
Cigarette smoke induces inflammation in humans.
“cigarette smoke and ageing, elicit a chronic low-grade systemic inflammatory response”
Review
Coronary artery disease concomitant with chronic obstructive pulmonary disease
European journal of clinical investigation26 Oct 2013
Trial sponsors
Wake Forest University Health Sciences
1 trialEarly phase 149 people